[1]
Nawaf Alanazi, “INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”, J Popl Ther Clin Pharmacol, vol. 29, no. 01, pp. 476–492, Jan. 2022, doi: 10.53555/68zhqm37.